Entacapone

Antiparkinsonian Drug

Drug class: Dopaminergic Antiparkinsonian Agent belongs to the catechol-O-methyltransferase (COMT) inhibitor.

Entacapone (COMTAN)（中文：恩他卡朋） is a medication primarily used in the treatment of Parkinson's disease, specifically to manage "wearing-off" sympotms associated with levodopa therapy. Below is detailed information regarding its drug class, strengths, usage, mechanism of action, and other relevant aspects.

Common Strengths of Entacapone

• 200 mg oral tablets are the standard strength available for entacapone

Drug Trade Names

COMTAN

• It is also available in fixed-dose combinations with levodopa and carbidopa under the brand name Stalevo.